[Long-term survival of a patient with esophageal cancer with brain metastasis after multidisciplinary therapy - a case report].

Abstract

A 70-year-old woman was admitted for difficulty in swallowing. Esophageal cancer (MtLt, type 3, T4N3M0, cStage IVa) was diagnosed in May 2010. The cancer was unresectable, and chemoradiotherapy (CRT) with TS-1 was initiated in June 2010, and a partial response (PR) was observed. After CRT, TS-1 was continued, but a brain metastasis was detected owing to the development of right hemiplegia in April 2012. Craniotomy and tumorectomy were performed, and the right hemiplegia improved. Pathological examination of the brain tumor indicated squamous cell carcinoma. Because of a recurrence of brain metastasis, a gamma knife procedure was performed in May 2012. Subsequently, several recurrences of brain metastases were diagnosed, and a total of 7 gamma knife procedures were performed up to January 2014. Although systemic chemotherapy (5-fluorouracil and cisplatin [FP], 5 courses)was administered, the patient showed progressive lung metastases in February 2013. The chemotherapy regimen was changed from FP to docetaxel (TXT), but the lung metastases continued to progress up to June 2013. The patient died in March 2014. Patients with esophageal cancer and metastases to the brain have poor prognosis, but the present patient survived approximately 2 years after first diagnosis of metastases to the brain after multidisciplinary therapy.

• Authors: Yuji Yamamoto, Hajime Tanaka, Takashi Maruyama, Hiroshi Matsuzaki, Toshiyuki Natsume, Akinari Miyazaki, Yayoi Satoh, Tetsutaro Satsuka, Takafumi Yoshioka, Yoko Kanada, Ryota Otsuka, Akitoshi Yanagihara, Masaya Yokoyama, Takushi Kobayashi
• Journal: Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 41 Issue 12 Pg. 2006-9 (Nov 2014) ISSN: 0385-0684 [Print] Japan
• PMID: 25731404 (Publication Type: Case Reports, English Abstract, Journal Article, Review)

Topics

• Aged
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Brain Neoplasms (secondary, therapy)
• Carcinoma, Squamous Cell (therapy)
• Chemoradiotherapy
• Esophageal Neoplasms (pathology, therapy)
• Fatal Outcome
• Female
• Humans
• Lung Neoplasms (secondary)